ResearcherArmy Medical UniversityNo recent work listed

Mengjie Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4822-8632; OpenAlex author ID A5100400235. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL. Co-author DOI 10.18632/aging.103830 ↗
Prognostic Values of CD38+CD101+PD1+CD8+ T Cells in Pancreatic Cancer. Co-author DOI 10.1080/08820139.2019.1566356 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Bing Ni · 2 shared papers, 2019–2020 · strength 0.22
- Paper Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL. DOI 10.18632/aging.103830 ↗
- Paper Prognostic Values of CD38+CD101+PD1+CD8+ T Cells in Pancreatic Cancer. DOI 10.1080/08820139.2019.1566356 ↗
Huaizhi Wang · 2 shared papers, 2019–2020 · strength 0.22
- Paper Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL. DOI 10.18632/aging.103830 ↗
- Paper Prognostic Values of CD38+CD101+PD1+CD8+ T Cells in Pancreatic Cancer. DOI 10.1080/08820139.2019.1566356 ↗
Zhiping Zhao · 1 shared paper, 2020 · strength 0.12
- Paper Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRAL. DOI 10.18632/aging.103830 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.